2 Top Beaten-Down Canadian Growth Stocks to Buy Right Now

Docebo (TSX:DCBO) is one of two beaten-down Canadian growth stocks that investors should check out amid growth’s latest tech wreck.

| More on:
Business success with growing, rising charts and businessman in background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

The stock market has been rather unkind to the high-growth names, many of which have been severely punished through no fault of their own. Inflation fears have set up an environment where pricey high-growth and tech stocks are viewed as rancid, especially those lacking profits. The growth stocks had their moment in the limelight, and now they’re on the retreat. Crises often pave the way for an acceleration in technological trends. As such, I believe many beaten-down Canadian growth stocks seem undervalued at the latest round of excessive selling.

The combination of higher inflation and fading pandemic tailwinds has many folks thinking that the peak has been reached by the fastest-growing tech darlings. I think that’s far from the case. In many instances, I suspect the pandemic-induced acceleration in secular tech trends such as e-commerce could reward growth investors over the next several years. In the meantime, there will be pain, but any such plunges ought to be bought on the way down by young investors who want market-beating results over the next decade and beyond.

Beaten-down Canadian growth stocks to watch

If you view the coronavirus crisis as a temporary tailwind for tech stocks, then sure, the pullback is warranted. However, if you think the crisis has propelled the technological adoption of new tech a few years into the future, many freshly sold-off growth stocks seem more like screaming buys. And in this piece, we’ll have a closer look at three names that I think are bargains that could fully recover from the tech wreck by year’s end.

Enter AI-leveraging e-learning play Docebo (TSX:DCBO) and supply-chain management software developer Kinaxis (TSX:KXS), which are down 23% and 33%, respectively, from their peak levels.


If any firm benefited from a crisis-induced acceleration in the adoption of innovative tech, it’s Docebo. The LMS (Learning Management System) software company was little known back in 2019. But now, it’s growing into a household name after having won many clients through 2020. The firm has helped many of its clients with the overwhelming process of the remote training of workforces. As the pandemic ends, Docebo may lose a bit of tailwind, but the growing adoption of LMS, I believe, will remain robust for years to come.

With Docebo stock fresh off a modest pullback, I’d look to buy shares before the next leg up. Docebo is growing absurdly fast. While such growth will decelerate on the other side of this pandemic, I still think it’s a mistake to give up on the name just because growth is out of favour on Wall Street.


Kinaxis (TSX:KXS) has fallen drastically out of favour in recent months, despite posting decent booking numbers and soaring new customer additions. With many supply chains worldwide still in disorder (think semiconductors), the demand for supply-chain management solutions is expected to remain robust.

Management is guiding for EBITDA margins to fall in the 11-14% range. I think the firm can easily hit the higher end of the range, as the company looks to re-accelerate its growth after a rocky patch. For a software-as-a-service company, Kinaxis stock is pretty cheap at just over 14 times sales.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool owns shares of Docebo Inc. The Motley Fool recommends KINAXIS INC.

More on Tech Stocks

Arrow descending on a graph
Tech Stocks

2 Industries That Saw the Worst Decline Last Month

The TSX has been declining at a sharp angle since the beginning of June. And two industries (crypto and cannabis)…

Read more »

Dividend Stocks

TFSA Investors: Turn $1,000 Into $10,000 in 10 Years

10-fold growth within a decade is rare but not unheard of. You can capture this growth either by predicting a…

Read more »

Growth from coins
Tech Stocks

Got $1,000? Buy These 3 Under-$20 Growth Stocks to Earn Higher Returns

These under-$20 growth stocks can deliver solid returns in the long run.

Read more »

Shopping card with boxes labelled REITs, ETFs, Bonds, Stocks
Tech Stocks

TFSA Investors: 3 TSX Stocks You’ll Regret Not Buying on the Dip

Among wide range of investments allowed in a TFSA, now is the time to invest in stocks.

Read more »

Tired or stressed businessman sitting on the walkway in panic digital stock market financial background
Tech Stocks

2 Stocks That Lost Over 50% in 2022

The recovery of the TSX’s tech superstar and a promising high-growth stock that lost more than 50% in 2022 is…

Read more »

Man holding magnifying glass over a document
Tech Stocks

Why BlackBerry Stock Looks Way Too Undervalued After Q1 Earnings

BB stock hasn’t seen any appreciation lately, despite its continued progress on the IVY platform and early signs of the…

Read more »

A stock price graph showing declines
Tech Stocks

BlackBerry Q1 Earnings: The Declining Revenue Streak Continues!

Will BB stock break below $6?

Read more »

A bull outlined against a field
Tech Stocks

After the Recent Fall, it’s Time to Turn Bullish on 2 TSX Growth Stocks

With the kind of lows these TSX stocks have seen, the negatives appear to be priced in.

Read more »